Alexandria Capital’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-50
| Closed | – | – | 586 |
|
|
2017
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 643 |
|
|
2017
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 605 |
|
|
2017
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 597 |
|
|
2016
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 577 |
|
|
2016
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 588 |
|
|
2016
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 585 |
|
|
2016
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 586 |
|
|
2015
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 632 |
|
|
2015
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 552 |
|
|
2015
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 574 |
|
|
2015
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 586 |
|
|
2014
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 548 |
|
|
2014
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 550 |
|
|
2014
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 572 |
|
|
2014
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 560 |
|
|
2013
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 569 |
|
|
2013
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 548 |
|
|
2013
Q2 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 601 |
|